7beta-hydroxysteroid dehydrogenase type 5 inhibitor ASP9521

A selective, orally bioavailable inhibitor of 17beta-hydroxysteroid dehydrogenase type 5 (17bHSD5, aldo-keto reductase 1C3; AKR1C3), with potential antineoplastic activity. Upon administration, ASP9521 selectively binds to and inhibits the activity of 17bHSD5. This prevents the conversion of the adrenal androgens dehydroepiandrosterone and androstenedione into 5-androstenediol and testosterone. By blocking testosterone production, ASP9521 may inhibit the growth of testosterone-dependent cancers such as castration-resistant prostate cancer (CRPC). 17bHSD5, expressed both in normal prostate tissue and in prostate cancer (PC), plays a crucial role in persistent production of androgens despite castration; its expression is associated with increased malignancy of PC. (NCI Dictionary)

YOU MAY ALSO LIKE

78 kDa Glucose-Regulated Protein

78 kDa glucose-regulated protein (654 aa, ~72kDa) is encoded by HSPA5 gene. The protein is intracellularly localized in the endoplasmic reticulum lumen,…

75th Growth Percentile

An indication that an individual ranks the same or more than 75 percent (top 25 percent) of the reference population for a…

72kDa Type IV Collagenase

72 kDa type IV collagenase (660 aa, ~74 kDa) is encoded by the human MMP2 gene. This protein is involved in both…

714-X

A product elaborated and marketed by the private Canadian laboratory. 714-X contains trimethylbicyclonitraminoheptane chloride, a nitrogenated camphor-derivative, and mineral salts in…

70% Ethyl Alcohol

An aqueous dilution of ethanol containing 70% ethanol by volume.

70-kD Heat-Shock Protein/MUC-1 Antigen

A fusion protein of the MUC-1 colorectal cancer surface marker with HSP70 as a carrier. In trials as a cancer…